{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Denis Chem Lab Ltd
When is the next results date for Denis Chem Lab Ltd?
The next results date for Denis Chem Lab Ltd is 14 February 2026.
Denis Chem Lab Ltd is Rated Sell
Denis Chem Lab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 March 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 January 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Why is Denis Chem Lab Ltd falling/rising?
On 23-Jan, Denis Chem Lab Ltd’s stock price rose by 3.54% to ₹78.78, continuing a short-term upward trend despite persistent long-term challenges. This article analyses the factors behind the recent price movement and the broader performance context.
Denis Chem Lab Ltd Falls to 52-Week Low of Rs.72.35 Amid Prolonged Downtrend
Denis Chem Lab Ltd’s shares declined to a fresh 52-week low of Rs.72.35 on 21 Jan 2026, marking a significant downturn amid a broader market slump and persistent underperformance relative to benchmarks and sector peers.
Denis Chem Lab Ltd Stock Falls to 52-Week Low of Rs.73.4
Denis Chem Lab Ltd’s shares touched a fresh 52-week low of Rs.73.4 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial performance and valuation metrics.
Denis Chem Lab Ltd is Rated Sell
Denis Chem Lab Ltd is rated Sell by MarketsMOJO, with this rating last updated on 11 Mar 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Denis Chem Lab Ltd is Rated Sell
Denis Chem Lab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 Mar 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with an up-to-date view of the company’s performance and outlook.
Denis Chem Lab Stock Falls to 52-Week Low of Rs.76 Amidst Sector Outperformance
Denis Chem Lab has reached a new 52-week low of Rs.76, marking a significant decline in its stock price as it continues to trade below all key moving averages, while the broader market and its sector show positive momentum.
Denis Chem Lab Stock Falls to 52-Week Low of Rs.77 Amidst Prolonged Downtrend
Denis Chem Lab, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.77, marking a significant decline amid a sustained downward trajectory over recent sessions.
Denis Chem Lab Stock Falls to 52-Week Low of Rs.78 Amidst Prolonged Downtrend
Denis Chem Lab has reached a new 52-week low of Rs.78, marking a significant decline in its stock price amid a sustained downward trend over recent sessions. The stock’s performance contrasts sharply with broader market indices, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.
Denis Chem Lab Stock Falls to 52-Week Low of Rs.81.5 Amidst Sector Underperformance
Denis Chem Lab's shares reached a fresh 52-week low of Rs.81.5 today, marking a significant decline as the stock underperformed its Pharmaceuticals & Biotechnology sector peers and broader market indices.
Denis Chem Lab Stock Falls to 52-Week Low of Rs.81.5 Amidst Sector Underperformance
Denis Chem Lab has reached a new 52-week low of Rs.81.5, marking a significant decline in its stock price as it underperforms the Pharmaceuticals & Biotechnology sector and broader market indices.
Denis Chem Lab Sees Revision in Market Evaluation Amidst Mixed Financial Signals
Denis Chem Lab, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting nuanced shifts across key analytical parameters. This adjustment comes amid a backdrop of subdued financial performance and challenging market conditions, prompting a reassessment of the company’s standing within its sector.
Denis Chem Lab Stock Falls to 52-Week Low of Rs.82.15
Denis Chem Lab has reached a new 52-week low of Rs.82.15, marking a significant decline in its stock price amid a challenging market environment. This level reflects a substantial drop from its 52-week high of Rs.193, underscoring the pressures faced by the company over the past year.
Why is Denis Chem Lab falling/rising?
As of 19-Nov, Denis Chem Lab Ltd's stock price is Rs 90.00, up 1.67% recently, but it has a year-to-date decline of -46.51%, indicating long-term challenges despite short-term gains and increased investor participation.
Is Denis Chem Lab overvalued or undervalued?
As of November 17, 2025, Denis Chem Lab is considered undervalued with a PE ratio of 16.73 and favorable valuation metrics compared to its industry peers, despite a recent stock underperformance of -47.04% against the Sensex.
Denis Chem Lab Q2 FY26: Profit Plunges 37% as Margin Pressures Mount
Denis Chem Lab Ltd., a Gujarat-based intravenous fluids and bulk drugs manufacturer, reported a sharp 37.39% year-on-year decline in net profit for Q2 FY26, falling to ₹2.21 crores from ₹3.53 crores in the same quarter last year. The ₹119.00 crore market capitalisation company witnessed its stock tumble 56.22% from its 52-week high of ₹193.00, currently trading at ₹84.49 as of November 14, 2025.
How has been the historical performance of Denis Chem Lab?
Denis Chem Lab has shown steady growth in net sales and profitability, with net sales increasing from 124.12 Cr in Mar'19 to 173.30 Cr in Mar'25, and profit after tax rising from 6.35 Cr to 8.08 Cr during the same period. The company has also improved its financial stability, reducing total debt significantly while maintaining positive cash flow.
Why is Denis Chem Lab falling/rising?
As of 14-Nov, Denis Chem Lab Ltd's stock is priced at Rs. 84.49, down 3.32% and recently hitting a 52-week low. The stock has underperformed significantly against the benchmark and its sector, with a year-to-date decline of 49.78%.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
